Globus Medical, Inc.
GMED
$91.04
-$0.04-0.04%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 363.08% | 776.83% | 178.51% | -16.19% | -42.05% |
| Total Depreciation and Amortization | 7.28% | 19.51% | 45.75% | 75.89% | 184.59% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -85.95% | -87.39% | 81.57% | 181.80% | 482.93% |
| Change in Net Operating Assets | 89.41% | 107.30% | 67.27% | 16.33% | -97.70% |
| Cash from Operations | 72.35% | 155.60% | 166.13% | 113.82% | 104.62% |
| Capital Expenditure | -11.88% | -40.63% | -35.35% | -47.47% | -64.38% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -1,332.07% | 18.74% | 98.37% | 94.04% | 94.60% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -89.56% | -81.91% | -79.78% | -106.35% | 20.39% |
| Cash from Investing | -239.81% | -256.91% | -99.22% | -158.11% | 418.29% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 128.18% | 394.35% | 979.80% | 790.85% | 57.18% |
| Repurchase of Common Stock | 20.95% | 32.65% | 39.48% | 60.83% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 49.26% | 48.42% | 47.99% | -467.47% | -401.40% |
| Cash from Financing | -94.84% | -69.46% | -56.18% | 88.05% | -1,805.35% |
| Foreign Exchange rate Adjustments | 237.63% | 691.99% | 742.50% | -88.30% | 147.99% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -173.15% | -274.06% | -21.39% | 0.10% | 136.01% |